Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 1
2020 3
2022 6
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop KL, Ravelli A, Betteridge N, Burmester GR, Bijlsma JW, Bykerk V, Caporali R, Choy EH, Codreanu C, Combe B, Crow MK, de Wit M, Emery P, Fleischmann RM, Gabay C, Hetland ML, Hyrich KL, Iagnocco A, Isaacs JD, Kremer JM, Mariette X, Merkel PA, Mysler EF, Nash P, Nurmohamed MT, Pavelka K, Poor G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen JS. Aletaha D, et al. Among authors: kastrati k. Ann Rheum Dis. 2023 Jun;82(6):773-787. doi: 10.1136/ard-2022-222784. Epub 2022 Aug 11. Ann Rheum Dis. 2023. PMID: 35953263
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.
Kastrati K, Aletaha D, Burmester GR, Chwala E, Dejaco C, Dougados M, McInnes IB, Ravelli A, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar MJH, Winthrop K, Smolen JS, Kerschbaumer A. Kastrati K, et al. RMD Open. 2022 Sep;8(2):e002359. doi: 10.1136/rmdopen-2022-002359. RMD Open. 2022. PMID: 36260501 Free PMC article.
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story.
Bonelli M, Kerschbaumer A, Kastrati K, Ghoreschi K, Gadina M, Heinz LX, Smolen JS, Aletaha D, O'Shea J, Laurence A. Bonelli M, et al. Among authors: kastrati k. Ann Rheum Dis. 2023 Nov 3:ard-2023-223850. doi: 10.1136/ard-2023-223850. Online ahead of print. Ann Rheum Dis. 2023. PMID: 37923366 Free article. Review.
Cancer Patient Motives and Expectations on Non-medical Practitioners.
Keinki C, Ahmadi E, Kastrati K, Zomorodbakhsch B, Hübner J; Working Group Prevention and Integrative Oncology of the German Cancer Society (PRIO). Keinki C, et al. Among authors: kastrati k. In Vivo. 2022 Sep-Oct;36(5):2505-2513. doi: 10.21873/invivo.12986. In Vivo. 2022. PMID: 36099132 Free PMC article.
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.
Grünwald V, Bergmann L, Brehmer B, Eberhardt B, Kastrati K, Gauler T, Gehbauer G, Gschwend J, Johannsen M, Klotz T, Protzel C, Schenck M, Staehler M. Grünwald V, et al. Among authors: kastrati k. World J Urol. 2022 Oct;40(10):2381-2386. doi: 10.1007/s00345-022-04015-1. Epub 2022 May 13. World J Urol. 2022. PMID: 35562599 Free PMC article.
COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report.
Anderle K, Machold K, Kiener HP, Bormann D, Hoetzenecker K, Geleff S, Prosch H, Laccone F, Heil PM, Petzelbauer P, Aletaha D, Blüml S, Kastrati K. Anderle K, et al. Among authors: kastrati k. BMC Rheumatol. 2022 Jul 13;6(1):42. doi: 10.1186/s41927-022-00271-1. BMC Rheumatol. 2022. PMID: 35821079 Free PMC article.
14 results